Versant Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$190K Buy
304
+1
+0.3% +$586 0.02% 635
2026
Q2
$160K Buy
303
+4
+1% +$1.85K 0.01% 712
2026
Q1
$144K Buy
299
+2
+0.7% +$1.02K 0.01% 713
2025
Q4
$167K Hold
297
– – 0.02% 560
2025
Q3
$153K Hold
297
– – 0.02% 561
2025
Q2
$93.2K Buy
297
+256
+624% +$76.9K 0.01% 696
2025
Q1
$12.5K Buy
41
+38
+1,267% +$12.8K ﹤0.01% 1607
2024
Q4
$997 Hold
3
– – ﹤0.01% 2196
2024
Q3
$1K Hold
3
– – ﹤0.01% 1743
2024
Q2
$1.24K Hold
3
– – ﹤0.01% 1625
2024
Q1
$1.21K Hold
3
– – ﹤0.01% 1491
2023
Q4
$920 Hold
3
– – ﹤0.01% 1537
2023
Q3
$726 Hold
3
– – ﹤0.01% 1619
2023
Q2
$721 Buy
+3
New +$623 ﹤0.01% 1721
2019
Q4
– Sell
-9
Closed – – 1493
2019
Q3
$0 Buy
+9
New +$680 ﹤0.01% 1501

Other funds holding MEDP

Versant Capital Management's MEDP Position: Q3 2026 in Review

Versant Capital Management increased its Medpace (MEDP) stake by 0.33% in Q3 2026, buying an estimated $586 and bringing the position to 304 shares worth $190K. The position accounts for 0.02% of the portfolio, ranked #635.

Versant Capital Management first reported a position in MEDP in Q3 2019 and has held it in 15 quarters since. 759 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Versant Capital Management held 304 shares of Medpace worth $190K as of Q3 2026.
  • Versant Capital Management bought 1 Medpace share in Q3 2026, an estimated $586.
  • Medpace made up 0.02% of Versant Capital Management's portfolio in Q3 2026, its #635 holding.
  • Versant Capital Management first reported a position in Medpace in Q3 2019 and has held it in 15 quarters since.
  • 759 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.